期刊文献+

链状铜配位聚合物的合成,晶体结构及量子化学计算(英文) 被引量:2

Synthesis,crystal structure and quantum chemical calculation of a Cu(Ⅱ) coordination polymer
原文传递
导出
摘要 在甲醇水混合溶剂中,以α-吡啶甲酸为配体与氢氧化铜合成了标题配合物[Cu(C_6H_4NO_2)2]_n·2nH_2O。配合物(C_(12)H_(12)CuN_2O_6,分子量为343.79),晶体属三斜晶系,空间群P_1,晶胞参数:a=0.51239(9)nm,b=0.76278(13)nm,c=0.92161(16)nm,α=74.921(3),β=84.404(3)°,γ=413(2),V=329.62(10)nm^3,Dc=1.732 cm^3,Z=1,F(000)=175,μ=1.69mm^(-1)。最终偏离因子R_1=0.0265,wR_2=0.0711。晶体结构表明:铜原子与2个α-吡啶甲酸4个氧原子,2个氮原子配位,形成六配位的变形四面体结构。本文对该配合物进行了量子化学计算。 The title complex has been synthesized with pyridine carboxylic acid and the copper hydroxide in the solvent mixture of water and methanol. It crystallizes (C12H12CuN2O6, Mr=343.79) in Triclinic space group P-1 with: a =0.51239(9) nm, b=0.76278(13) nm, c = 0.92161(16) nm, α=74.921(3), β=84.404(3)°, γ=71.413(2); V=329.62(10) nm3, Dc=1.732 cm3, Z=1, F(000)= 175,μ=1.69 mm-1, R1 = 0.0265, wR2 =0.0711. The crystal structure shows that the copper atom is coordinated with four oxygen atoms and nitrogen atoms from two pyridine carboxylic acid molecules, forming a distorted octahedral coordination geometry. The stability, some frontier molecular orbital energies and composition characteristics of some frontier molecular orbital of the complex have been investigated.
出处 《计算机与应用化学》 CAS CSCD 北大核心 2012年第12期1471-1474,共4页 Computers and Applied Chemistry
基金 supported by the the the Fund of Hunan Provincial Natural Science Foundation of China(No.11JJ9006) the Hunan Provincial innovative platform open fund project(11K009) Science and Technology Committee of Hunan Province(2012WK3029,2012GK3031)
关键词 铜(Ⅱ)配位聚合物 晶体结构 量子化学计算 Copper(Ⅱ) complex Crystal Structure Quantum Chemical Calculation
  • 相关文献

参考文献6

二级参考文献114

  • 1邝代治,冯泳兰,王剑秋,张复兴,许志锋.H…Cl(O),π…π作用的三维配合物[Cu(phen)_2 Cl(ClO_4)]_n的结构和量子化学研究(英文)[J].计算机与应用化学,2006,23(12):1188-1192. 被引量:8
  • 2Taylor H F W.Cement Chemistry.London:Thomas Telford Publishing,1997.5.
  • 3Roberts H W,Toth J M,Berzins D W,et al.Dent.Mater.,2008,24(2):149-164.
  • 4Zhao W Y,Wang J Y,Zhai W Y,et al.Biomaterials,2005,26(31):6113-6121.
  • 5Briak H E,Durand D,Boudeville P,et al.J.Mater.Sci.:Mater.Med.,2008,19(2):737-744.
  • 6Boudeville P,Serraj S,Leloup J M,et al.J.Mater.Sci.:Mater.Med.,1999,10(2):99-109.
  • 7SUN Hao-Liang(孙浩亮),GUO Da-Gang(郭大刚),XU Ke-Wei (徐可为),et al.J.Chin.Ceram.Soc.(Guisuanyan Xuebao),2005,330):115-119.
  • 8TANG Pei-Fu(唐佩福),HAO Li-Bo(郝立波),MAO Ke-Ya (毛克亚),et al.Biomed.Eng.Clin.Med.(Shengwu Yixue Gongcheng Yu Linehuang),2005,9(5):267-270.
  • 9DAI Hong-Lian(戴红莲),CHEN Xiao-Ming(陈晓明),HUANG Fu-Long(黄福龙),et al.J.Wuhan Univ.Technol.(Wuhan Ligong Daxue Xuebao),2006,28(1):30-34.
  • 10HAN Bing(韩冰),YIN Yu-Ji(尹玉姬),LI Zong-Yan(李宗燕),et al.Chem.Ind.Eng.Prog.(Huagong Jinzhan),2006,25(5):495-501.

共引文献9

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部